Six‐Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost‐Saving Analysis

There is limited evidence to guide optimal frequency of surveillance bloodwork for haemodialysis patients. In September 2023, surveillance bloodwork frequency was reduced from monthly to 6-weekly across 4 Illawarra-Shoalhaven dialysis units. We retrospectively evaluated actual frequency of blood tests, safety (all-cause hospitalisations, hospitalisations for hyperkalaemia, percentage of potassium and haemoglobin levels in target ranges), cost-savings and environmental impact (reduction in carbon emissions and waste generation) of 6-weekly versus monthly scheduled bloodwork for clinically stable patients receiving in-facility haemodialysis during the 12-months before and after this practice change. Staff perspectives were gathered via survey. We analysed 99 patients with monthly surveillance bloodwork and 101 patients with 6-weekly bloodwork. After reducing to 6-weekly scheduled bloodwork, frequency of FBC/EUC/CMP blood tests decreased from 48.3 to 34.9 per patient-year. Comparing 6-weekly versus monthly groups, there was no increase in percentage of patients with ≥ 1 hospitalisation (72% vs. 73.5%, p = 0.70), hospitalisation for hyperkalaemia (0.8% vs. 0.9%, p = 0.92); percentage of patients with potassium levels (3.5-5.9 mmol/L) was similar (86.0% vs. 86.2%, p = 0.88). Proportion of haemoglobin levels in target range (100-115 g/L) decreased from 45.4% to 38.5% (p < 0.01) but with no clear changes in Erythropoietin Stimulating Agent use. Overall, there were 3.8 fewer blood draws, 8.7 fewer blood tubes used, $AUD201.44 saved in pathology costs and carbon emissions reduced by 1.03 kg per patient-year. Of 58 dialysis nurses, 47 (81%) responded to a survey and indicated the practice change was acceptable (38/47, 81%). Reducing surveillance bloodwork frequency to 6-weekly for haemodialysis patients delivered substantial cost-savings and had positive environmental benefits without compromising safety. Strong engagement with dialysis staff supports its scalability and sustainability.

Authors

Institutions

Publication Details

Journal
Nephrology
Published
2026-04-01
DOI
https://doi.org/10.1111/nep.70202
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Six‐Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost‐Saving Analysis

Debbie Pugh, Jeffrey T. Ha, Karumathil Murali, Jenny H. C. Chen et al.
Nephrology
Dialysis and Renal Disease Management
article

Six‐Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost‐Saving Analysis

Debbie Pugh, Jeffrey T. Ha, Karumathil Murali, Jenny H. C. Chen, Donia George, Kelly Lambert, Wing‐Chi Gigi Yeung, Samantha Staker, Monica Kwiatkowski, Jake Watson
article en

Abstract

There is limited evidence to guide optimal frequency of surveillance bloodwork for haemodialysis patients. In September 2023, surveillance bloodwork frequency was reduced from monthly to 6-weekly across 4 Illawarra-Shoalhaven dialysis units. We retrospectively evaluated actual frequency of blood tests, safety (all-cause hospitalisations, hospitalisations for hyperkalaemia, percentage of potassium and haemoglobin levels in target ranges), cost-savings and environmental impact (reduction in carbon emissions and waste generation) of 6-weekly versus monthly scheduled bloodwork for clinically stable patients receiving in-facility haemodialysis during the 12-months before and after this practice change. Staff perspectives were gathered via survey. We analysed 99 patients with monthly surveillance bloodwork and 101 patients with 6-weekly bloodwork. After reducing to 6-weekly scheduled bloodwork, frequency of FBC/EUC/CMP blood tests decreased from 48.3 to 34.9 per patient-year. Comparing 6-weekly versus monthly groups, there was no increase in percentage of patients with ≥ 1 hospitalisation (72% vs. 73.5%, p = 0.70), hospitalisation for hyperkalaemia (0.8% vs. 0.9%, p = 0.92); percentage of patients with potassium levels (3.5-5.9 mmol/L) was similar (86.0% vs. 86.2%, p = 0.88). Proportion of haemoglobin levels in target range (100-115 g/L) decreased from 45.4% to 38.5% (p < 0.01) but with no clear changes in Erythropoietin Stimulating Agent use. Overall, there were 3.8 fewer blood draws, 8.7 fewer blood tubes used, $AUD201.44 saved in pathology costs and carbon emissions reduced by 1.03 kg per patient-year. Of 58 dialysis nurses, 47 (81%) responded to a survey and indicated the practice change was acceptable (38/47, 81%). Reducing surveillance bloodwork frequency to 6-weekly for haemodialysis patients delivered substantial cost-savings and had positive environmental benefits without compromising safety. Strong engagement with dialysis staff supports its scalability and sustainability.

NephrologyVol. 31(4)
University of Wollongong (AU), Wollongong Hospital (AU), UNSW Sydney (AU), The George Institute for Global Health (AU)
Australian and New Zealand Society of Nephrology, Renal Society of Australasia, University of New South Wales
Responsible consumption and production
Openalex Percentile: Top 23%
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.